存心 发表于 2025-3-23 12:53:39

http://reply.papertrans.cn/1/56/5538/5538-11.png

crumble 发表于 2025-3-23 15:55:30

Submitted on: 01 March 2003.
Revised on: 25 June 2003.
Accepted on: 23 July 2003.

___________________CLINICA CHIMICA ACTA---ELSEVIER

CAMP 发表于 2025-3-23 19:55:34

http://reply.papertrans.cn/1/56/5538/5538-13.png

Encoding 发表于 2025-3-24 01:36:04

Submitted on: 09 August 1999.
Revised on: 02 December 1999.
Accepted on: 13 January 2000.

___________________CLINICA CHIMICA ACTA---ELSEVIER

FEMUR 发表于 2025-3-24 06:19:14

Submitted on: 20 February 2007.
Revised on: 10 June 2007.
Accepted on: 19 July 2007.

___________________CLINICA CHIMICA ACTA---ELSEVIER

Lipoprotein(A) 发表于 2025-3-24 10:03:08

http://reply.papertrans.cn/1/56/5538/5538-16.png

光滑 发表于 2025-3-24 12:24:01

Submitted on: 17 April 1999.
Revised on: 17 July 1999.
Accepted on: 05 August 1999.

___________________CLINICA CHIMICA ACTA---ELSEVIER

Aqueous-Humor 发表于 2025-3-24 18:18:01

Submitted on: 02 May 2008.
Revised on: 22 August 2008.
Accepted on: 17 September 2008.

___________________CLINICA CHIMICA ACTA---ELSEVIER

Optimum 发表于 2025-3-24 19:14:59

Submitted on: 30 March 2002.
Revised on: 18 May 2002.
Accepted on: 30 June 2002.

___________________CLINICA CHIMICA ACTA---ELSEVIER

Microgram 发表于 2025-3-25 00:55:37

http://reply.papertrans.cn/1/56/5538/5538-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊CLINICA CHIMICA ACTA 2024/2025影响因子:3.225 (CLIN CHIM ACTA) (0009-8981). (MEDICAL LABORATORY TECHNOLOGY)(医学实验室技术)Sc